2012 ISPE Annual Meeting to Reflect Association's New Strategic Plan
Published: Oct 11, 2012
"ISPE has made it a priority to expand our overall educational offerings to include more regulatory and strategic discussions as part of our transition to an approach that considers the entire product lifecycle," said ISPE President and CEO Nancy Berg. "This year's Annual Meeting education program reflects that, and as a result, we are seeing record-setting global registrations. This year's meeting will be a brand-new experience for our Members and the industry professionals and regulators who attend."
Among the elevated offerings at this year's Annual Meeting are a plenary session with presentations from the FDA's Dr. Stephen Spielberg and the IMS Institute for Healthcare Informatics' Murray Aitken, an Executive Series and an International Regulatory Summit. Many education sessions, including those in the Executive Series, are expected to fill to capacity in the coming weeks.
The enhanced education program and International Regulatory Summit at the 2012 ISPE Annual Meeting are also drawing a record number of regulators as both speakers and attendees. In addition to Dr. Stephen Spielberg, confirmed regulators from the US FDA to-date include Jeffrey Baker, Ilisa Bernstein, Rick Friedman, Bogdan Kurtyka, Steve Lynn, Christina Moore, Yingxu Ping and Lawrence Yu. Other confirmed regulators include Mark Birse (MHRA), Joyce N. Cirunay (FDA Philippines), Dr. Rodolfo Mocchetto (ANMAT), Song Shufen and Liu Yuan (CCD, SFDA), among others.
ISPE has released a new video to highlight the program enhancements delegates will see at this year's meeting. Additional information, including complete program, speaker, and registration information, is available on the 2012 ISPE Annual Meeting website.
ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit www.ISPE.org for more information.